Pulmuone Co., Ltd. (017810.KS)
KRW 11120.0
(0.63%)
KRW 11120.0
(0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2993.46 Billion | 2838.3 Billion | 2518.89 Billion | 2311.19 Billion | 2381.45 Billion | 2271.97 Billion |
| Cost of Revenue | 2266.8 Billion | 2137.88 Billion | 1862.66 Billion | 1699.7 Billion | 1791.42 Billion | 1712.94 Billion |
| Gross Profit | 726.66 Billion | 700.41 Billion | 656.23 Billion | 611.49 Billion | 590.02 Billion | 559.03 Billion |
| Operating Expenses | 664.9 Billion | 674.08 Billion | 617.72 Billion | 565.52 Billion | 559.45 Billion | 518.78 Billion |
| Selling, General and Administrative Expenses | 635.03 Billion | 373.63 Billion | 344.88 Billion | 298.65 Billion | 308.11 Billion | 303.48 Billion |
| Research and Development Expenses | 29.86 Billion | 27.62 Billion | 28.28 Billion | 32.92 Billion | 26.78 Billion | 23.45 Billion |
| Other Expenses | - | 272.81 Billion | 244.54 Billion | 233.93 Billion | 224.54 Billion | 6.42 Billion |
| Cost and Expenses | 2931.7 Billion | 2811.97 Billion | 2480.38 Billion | 2265.22 Billion | 2350.88 Billion | 2231.72 Billion |
| Operating Income | 61.76 Billion | 40.7 Billion | 54.19 Billion | 45.97 Billion | 30.57 Billion | 40.24 Billion |
| Interest Expense | 56.16 Billion | 39.16 Billion | 29.05 Billion | 27.2 Billion | 25.69 Billion | 14.09 Billion |
| Income Tax Expense | 954.08 Million | 18.55 Billion | 13.2 Billion | 6.12 Billion | 14.42 Billion | 14.95 Billion |
| Earnings before Tax | 14.31 Billion | -18.41 Billion | 13.5 Billion | 17.95 Billion | 6.88 Billion | 27.59 Billion |
| Net Income | 9.36 Billion | -36.96 Billion | 304.15 Million | 11.83 Billion | -7.53 Billion | 23.41 Billion |
| Earnings Per Share Basic | 103.65 | -1005.35 | 8.26 | 317.64 | -202.34 | 55.10 |
| Earnings Per Share Diluted | 204.81 | -1005.35 | 8.26 | 286.60 | -202.34 | 55.10 |
| Weighted Average Shares Outstanding | 90.35 Million | 36.77 Million | 36.81 Million | 37.25 Million | 37.24 Million | 425.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.72 Million | 36.77 Million | 36.81 Million | 41.28 Million | 37.24 Million | 425.05 Million |
| Gross Margin | 0.24 | 0.25 | 0.26 | 0.26 | 0.25 | 0.25 |
| EBIT Margin | 0.07 | 0.06 | 0.07 | 0.08 | 0.06 | 0.05 |
| Profit Margin | 0.00 | -0.01 | 0.00 | 0.01 | -0.00 | 0.01 |
| EBITDA | 209.95 Billion | 159.17 Billion | 173.85 Billion | 163.37 Billion | 140.76 Billion | 109.74 Billion |
| Earnings Before Tax Margin | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 793.04 Billion | 769.29 Billion | 761.98 Billion | 2993.46 Billion | 746.05 Billion | 755.38 Billion |
| Cost of Revenue | 598.55 Billion | 582.58 Billion | 586.81 Billion | 2266.8 Billion | 549.6 Billion | 558.35 Billion |
| Gross Profit | 194.48 Billion | 186.71 Billion | 175.16 Billion | 726.66 Billion | 196.45 Billion | 197.03 Billion |
| Operating Expenses | 177.63 Billion | 171.05 Billion | 164.2 Billion | 664.9 Billion | -174.55 Billion | -180.25 Billion |
| Selling, General and Administrative Expenses | 169.87 Billion | 163.74 Billion | 156.39 Billion | - | 174.55 Billion | 180.25 Billion |
| Research and Development Expenses | 7.76 Billion | 7.3 Billion | 7.81 Billion | - | 6.97 Billion | 7.48 Billion |
| Other Expenses | -184.42 Billion | 529.19 Million | 997.49 Million | 2.76 Billion | -349.11 Billion | -360.5 Billion |
| Cost and Expenses | 776.19 Billion | 753.63 Billion | 751.02 Billion | 2931.7 Billion | 549.6 Billion | 558.35 Billion |
| Operating Income | 16.84 Billion | 15.65 Billion | 10.95 Billion | 61.76 Billion | 21.89 Billion | 16.77 Billion |
| Interest Expense | 16.4 Billion | 16.92 Billion | 13.73 Billion | 56.16 Billion | 14.67 Billion | 14.1 Billion |
| Income Tax Expense | -969.73 Million | 2.68 Billion | -2.95 Billion | 954.08 Million | 2.92 Billion | 564.04 Million |
| Earnings before Tax | 4.45 Billion | 4.51 Billion | -1.85 Billion | 14.96 Billion | 10.1 Billion | 4.09 Billion |
| Net Income | 1.79 Billion | 2.4 Billion | 87.45 Million | 9.36 Billion | 8.6 Billion | 4.8 Billion |
| Earnings Per Share Basic | 48.81 | 2.42 | 2.38 | - | 178.71 | 57.37 |
| Earnings Per Share Diluted | 47.94 | 2.41 | 2.38 | - | 178.41 | 57.28 |
| Weighted Average Shares Outstanding | 36.77 Million | 36.77 Million | 36.77 Million | 36.77 Million | 36.77 Million | 36.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.66 Million | 36.86 Million | 36.77 Million | 45.72 Million | 36.83 Million | 36.82 Million |
| Gross Margin | 0.25 | 0.24 | 0.23 | 0.24 | 0.26 | 0.26 |
| EBIT Margin | 0.07 | 0.07 | 0.06 | - | 0.26 | 0.26 |
| Profit Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| EBITDA | 56.32 Billion | 55.12 Billion | 49.21 Billion | - | 196.45 Billion | 197.03 Billion |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 |
FIBIH
ALZCUR
ELBM
DAVANGERE
300745
HMLA